Cargando…

Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis

BACKGROUND: Innate T helper type 2 (Th2) immune responses mediated by interleukin (IL)-33, thymic stromal lymphopoietin (TSLP), and IL-25 have been shown to play an important role in pulmonary fibrosis of animal models; however, their clinical implications remain poorly understood. METHODS: TSLP, IL...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jong-Uk, Chang, Hun Soo, Lee, Hyeon Ju, Jung, Chang An, Bae, Da Jeong, Song, Hyun Ji, Park, Jong Sook, Uh, Soo-Taek, Kim, Young Hoon, Seo, Ki-Hyun, Park, Choon-Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312598/
https://www.ncbi.nlm.nih.gov/pubmed/28202030
http://dx.doi.org/10.1186/s12890-017-0380-z
_version_ 1782508234552115200
author Lee, Jong-Uk
Chang, Hun Soo
Lee, Hyeon Ju
Jung, Chang An
Bae, Da Jeong
Song, Hyun Ji
Park, Jong Sook
Uh, Soo-Taek
Kim, Young Hoon
Seo, Ki-Hyun
Park, Choon-Sik
author_facet Lee, Jong-Uk
Chang, Hun Soo
Lee, Hyeon Ju
Jung, Chang An
Bae, Da Jeong
Song, Hyun Ji
Park, Jong Sook
Uh, Soo-Taek
Kim, Young Hoon
Seo, Ki-Hyun
Park, Choon-Sik
author_sort Lee, Jong-Uk
collection PubMed
description BACKGROUND: Innate T helper type 2 (Th2) immune responses mediated by interleukin (IL)-33, thymic stromal lymphopoietin (TSLP), and IL-25 have been shown to play an important role in pulmonary fibrosis of animal models; however, their clinical implications remain poorly understood. METHODS: TSLP, IL-25, and IL-33 concentrations were measured in bronchoalveolar lavage fluids obtained from normal controls (NCs; n = 40) and from patients with idiopathic pulmonary fibrosis (IPF; n = 100), non-specific interstitial pneumonia (NSIP; n = 22), hypersensitivity pneumonitis (HP; n = 20), and sarcoidosis (n = 19). RESULTS: The TSLP and IL-33 levels were significantly higher in patients with IPF relative to the NCs (p = 0.01 and p = 0.0001, respectively), NSIP (p = 4.95E − 7 and p = 0.0002, respectively), HP (p = 0.00003 and p = 0.000005, respectively), and sarcoidosis groups (p = 0.003 and p = 0.0001, respectively). However, the IL-25 levels were not significantly different between NC and IPF group (p = 0.432). Receiver operating characteristic curves of the TSLP and IL-33 levels revealed clear differences between the IPF and NC groups (AUC = 0.655 and 0.706, respectively), as well as between the IPF and the other lung disease groups (AUC = 0.786 and 0.781, respectively). Cut-off values of 3.52 pg/μg TSLP and 3.77 pg/μg IL-33 were shown to differentiate between the IPF and NC groups with 99.2 and 94.3% accuracy. Cut-off values of 4.66 pg/μg TSLP and 2.52 pg/μg IL-33 possessed 99.4 and 93.2% accuracy for differentiating among the IPF and other interstitial lung disease groups. CONCLUSIONS: Innate immune responses may be associated with the development of IPF. Furthermore, the IL-33 and TSLP levels in BAL fluids may be useful for differentiating IPF from other chronic interstitial lung diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12890-017-0380-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5312598
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53125982017-02-24 Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis Lee, Jong-Uk Chang, Hun Soo Lee, Hyeon Ju Jung, Chang An Bae, Da Jeong Song, Hyun Ji Park, Jong Sook Uh, Soo-Taek Kim, Young Hoon Seo, Ki-Hyun Park, Choon-Sik BMC Pulm Med Research Article BACKGROUND: Innate T helper type 2 (Th2) immune responses mediated by interleukin (IL)-33, thymic stromal lymphopoietin (TSLP), and IL-25 have been shown to play an important role in pulmonary fibrosis of animal models; however, their clinical implications remain poorly understood. METHODS: TSLP, IL-25, and IL-33 concentrations were measured in bronchoalveolar lavage fluids obtained from normal controls (NCs; n = 40) and from patients with idiopathic pulmonary fibrosis (IPF; n = 100), non-specific interstitial pneumonia (NSIP; n = 22), hypersensitivity pneumonitis (HP; n = 20), and sarcoidosis (n = 19). RESULTS: The TSLP and IL-33 levels were significantly higher in patients with IPF relative to the NCs (p = 0.01 and p = 0.0001, respectively), NSIP (p = 4.95E − 7 and p = 0.0002, respectively), HP (p = 0.00003 and p = 0.000005, respectively), and sarcoidosis groups (p = 0.003 and p = 0.0001, respectively). However, the IL-25 levels were not significantly different between NC and IPF group (p = 0.432). Receiver operating characteristic curves of the TSLP and IL-33 levels revealed clear differences between the IPF and NC groups (AUC = 0.655 and 0.706, respectively), as well as between the IPF and the other lung disease groups (AUC = 0.786 and 0.781, respectively). Cut-off values of 3.52 pg/μg TSLP and 3.77 pg/μg IL-33 were shown to differentiate between the IPF and NC groups with 99.2 and 94.3% accuracy. Cut-off values of 4.66 pg/μg TSLP and 2.52 pg/μg IL-33 possessed 99.4 and 93.2% accuracy for differentiating among the IPF and other interstitial lung disease groups. CONCLUSIONS: Innate immune responses may be associated with the development of IPF. Furthermore, the IL-33 and TSLP levels in BAL fluids may be useful for differentiating IPF from other chronic interstitial lung diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12890-017-0380-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-15 /pmc/articles/PMC5312598/ /pubmed/28202030 http://dx.doi.org/10.1186/s12890-017-0380-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Lee, Jong-Uk
Chang, Hun Soo
Lee, Hyeon Ju
Jung, Chang An
Bae, Da Jeong
Song, Hyun Ji
Park, Jong Sook
Uh, Soo-Taek
Kim, Young Hoon
Seo, Ki-Hyun
Park, Choon-Sik
Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis
title Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis
title_full Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis
title_fullStr Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis
title_full_unstemmed Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis
title_short Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis
title_sort upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312598/
https://www.ncbi.nlm.nih.gov/pubmed/28202030
http://dx.doi.org/10.1186/s12890-017-0380-z
work_keys_str_mv AT leejonguk upregulationofinterleukin33andthymicstromallymphopoietinlevelsinthelungsofidiopathicpulmonaryfibrosis
AT changhunsoo upregulationofinterleukin33andthymicstromallymphopoietinlevelsinthelungsofidiopathicpulmonaryfibrosis
AT leehyeonju upregulationofinterleukin33andthymicstromallymphopoietinlevelsinthelungsofidiopathicpulmonaryfibrosis
AT jungchangan upregulationofinterleukin33andthymicstromallymphopoietinlevelsinthelungsofidiopathicpulmonaryfibrosis
AT baedajeong upregulationofinterleukin33andthymicstromallymphopoietinlevelsinthelungsofidiopathicpulmonaryfibrosis
AT songhyunji upregulationofinterleukin33andthymicstromallymphopoietinlevelsinthelungsofidiopathicpulmonaryfibrosis
AT parkjongsook upregulationofinterleukin33andthymicstromallymphopoietinlevelsinthelungsofidiopathicpulmonaryfibrosis
AT uhsootaek upregulationofinterleukin33andthymicstromallymphopoietinlevelsinthelungsofidiopathicpulmonaryfibrosis
AT kimyounghoon upregulationofinterleukin33andthymicstromallymphopoietinlevelsinthelungsofidiopathicpulmonaryfibrosis
AT seokihyun upregulationofinterleukin33andthymicstromallymphopoietinlevelsinthelungsofidiopathicpulmonaryfibrosis
AT parkchoonsik upregulationofinterleukin33andthymicstromallymphopoietinlevelsinthelungsofidiopathicpulmonaryfibrosis